A novel CYR61/ER connection is regulates anti-estrogen resistance in breast cancer.

被引：0
|
作者：
Espinoza, I
Rasor, G.
Liu, H.
Lupu, R.
机构：
[1] Evanston NW Healthcare Res Inst, Evanston, IL USA
[2] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Cyr61 promotes breast tumorigenesis and cancer progression
    Miaw-Sheue Tsai
    Daphne F Bogart
    Jessica M Castañeda
    Patricia Li
    Ruth Lupu
    Oncogene, 2002, 21 : 8178 - 8185
  • [2] Cyr61 promotes breast tumorigenesis and cancer progression
    Tsai, MS
    Bogart, DF
    Castañeda, JM
    Li, P
    Lupu, R
    ONCOGENE, 2002, 21 (53) : 8178 - 8185
  • [3] Anti-estrogen cross resistance in human breast cancer
    De Soto, Joseph A.
    Fryar, Elizabeth B.
    Grissom, Felix E.
    Southerland, William M.
    Green, Sidney
    Bowen, Donnell
    Chemist, 2006, 83 (02):
  • [4] Breast cancer -: Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease
    Xie, D
    Miller, CW
    O'Kelly, J
    Nakachi, K
    Sakashita, A
    Said, JW
    Gornbein, J
    Koeffler, HP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 14187 - 14194
  • [5] IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
    Sarkissyan, Suren
    Sarkissyan, Marianna
    Wu, Yanyuan
    Cardenas, Jessica
    Koeffler, H. Phillip
    Vadgama, Jaydutt V.
    PLOS ONE, 2014, 9 (07):
  • [6] Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61
    Bauerschmitz, Gerd
    Huechel, Silke
    Gallwas, Julia
    Gruendker, Carsten
    CANCER GENOMICS & PROTEOMICS, 2023, 20 (06) : 531 - 538
  • [7] Serum CYR61 as a potential biomarker to improve breast cancer diagnostics
    Lin, Zhen
    Song, Yanfang
    Qiu, Yaling
    Shi, Pengchong
    Zeng, Menglu
    Cao, Yingping
    Zhu, Xianjin
    BIOMARKERS IN MEDICINE, 2022, 16 (15) : 1121 - 1128
  • [8] Development of novel breast cancer therapeutics for anti-estrogen resistant breast cancer
    Ma, Yongxian
    Preet, Anju
    Hu, Changyan
    Kumar, Akshay
    Ma, James
    Tomita, York
    Rosen, Eliot M.
    CANCER RESEARCH, 2013, 73 (08)
  • [9] CYR61 COnfers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma
    Jia, Xiaoqing
    Liu, Guangyu
    Cheng, Jingyi
    Shen, Zhenzhou
    Shao, Zhimin
    CURRENT CANCER DRUG TARGETS, 2017, 17 (02) : 191 - 197
  • [10] Expression and regulation of Cyr61 in human breast cancer cell lines
    Miaw-Sheue Tsai
    Daphne F Bogart
    Patricia Li
    Inderjit Mehmi
    Ruth Lupu
    Oncogene, 2002, 21 : 964 - 973
12345